Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Lafora disease (LD) is a fatal, progressive epilepsy linked to mutations in laforin or malin.
• Accumulation of abnormal glycogen (Lafora bodies) in neurons is a hallmark of LD.
• Previous hypotheses suggested glycogen hyperphosphorylation causes insolubility and LD.

Purpose of the Study:

• To investigate the precise function of laforin and malin in glycogen metabolism and LD pathogenesis.
• To challenge the prevailing hypothesis that glycogen hyperphosphorylation is the primary cause of LD.
• To determine the role of autophagy in LD.

Main Methods:

• Quantification of brain glycogen phosphate, glycogen content, and chain lengths in various laforin- or malin-deficient mouse models.
• Assessment of Lafora bodies (LBs) and autophagy markers.
• Utilized mouse models expressing phosphatase-inactive laforin.

Main Results:

• Phosphatase-inactive laforin corrected glycogen chain lengths, not hyperphosphorylation, in laforin-deficient mice, preventing LBs.
• No correction was observed in malin-deficient mice treated with phosphatase-inactive laforin.
• Autophagy impairment is not essential for LD development.

Conclusions:

• Laforin's primary role is to regulate glycogen chain length in a malin-dependent manner.
• Loss of laforin's control over glycogen chain length is the underlying cause of Lafora disease.
• The study refutes the necessity of autophagy impairment in LD pathogenesis.